Federal contractor · public award history
MARLEX PHARMACEUTICALS INC
DBA MARLEX PHARMACEUTICALS I
Parent: MARLEX PHARMACEUTICALS INC VSSNJEFMPLB3
- Awards we know about
- 5
- Typical size
- —
- Middle of their public awards
- Dollars on those awards
- $0
SAM.gov registration
Public extract 2026-07-05
- Status
- Active
- Purpose of registration
- All awards (Z2)
- Registration expires
- Oct 30, 2026
- Activation date
- Nov 3, 2025
- Primary NAICS (SAM)
- 325412
Business types (SAM)
Registration fields from the official SAM.gov public entity extract (monthly bulk). Not a substitute for live SAM checks.
From official USAspending contract records — not a capability rating, past-performance score, or recommendation to team or bid.
Awarding agencies
- Department of Veterans Affairs (5)
Industries & product codes
Award history
- Department of Veterans Affairs—
65 I B, DRUGS, PHARMACEUTICALS, & HEMATOLOGY RELATED PRODUCTS, FSS CONTRACT AWARD
- Department of Veterans Affairs—
NEW AWARD FOR ROPINIROLE TABLETS WITH MARLEX PHARMACEUTICALS. PERIOD OF PERFORMANCE IS AUGUST 28, 2021 TO AUGUST 27, 2022 WITH FOUR ONE-YEAR OPTIONS.
- Department of Veterans Affairs—
NEW AWARD FOR ALENDRONATE TABLETS WITH MARLEX PHARMACEUTICALS, INC. PERIOD OF PERFORMANCE IS MAY 21ST, 2021 TO MAY 20TH, 2022 WITH FOUR ONE-YEAR OPTIONS.
- Department of Veterans Affairs—
NEW AWARD FOR EZETIMIBE TABLETS WITH MARLEX PHARMACEUTICALS. PERIOD OF PERFORMANCE IS APRIL 28, 2024 - APRIL 27, 2025 WITH FOUR ONE-YEAR OPTIONS
- Department of Veterans Affairs—
65 I B, DRUGS, PHARMACEUTICALS,&HEMATOLOGY RELATED PRODUCTS, FSS CONTRACT AWARD
Intelligence only — not legal advice, not a past-performance evaluation, and not a recommendation to team or bid. Verify on USAspending and SAM.gov.